Accent Microcell

Accent Microcell CROIC

The Cash Return on Invested Capital (CROIC) of Accent Microcell (ACCENTMIC.NS) as of Nov 4, 2026 is 6.38 %. In the previous year, Cash Return on Invested Capital (CROIC) was 5.29 % — a change of 20.57% (higher).

CROIC

6.38 %

YoY

20.57%

Last updated:

Cash Return on Invested Capital (CROIC) of Accent Microcell is 2025 6.38 % . Cash Return on Invested Capital (CROIC) of Accent Microcell was 2024 5.29 % . It decreases by 20.57% higher compared to the previous year.

The Accent Microcell CROIC history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CROIC
Date
CROIC
Jan 1, 2023
15.11 INR
Jan 1, 2024
5.29 INR
Jan 1, 2025
6.38 INR
The Accent Microcell CROIC history
YEARCROICYoY
6.38 %+20.57%
5.29 %-65.00%
15.11 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Accent Microcell Stock analysis

What does Accent Microcell do? Accent Microcell Ltd develops, processes, and markets a wide range of pharmaceutical products including bulk drugs, formulations in all forms, feed and dietary supplements, and healthcare products across allopathic, ayurvedic, umami, homeopathic, and other branches. The company manufactures and sells antibiotics, herbal, bacteriological, and biological products, as well as insecticides, pesticides, fungicides, and disinfectants. With over 200 products in its portfolio, Accent Microcell targets therapeutic segments in human and veterinary healthcare, offering both raw materials and finished preparations for diverse medical applications. The company's product range includes microcrystalline cellulose powder and alpha cellulose powder, which are used as pharmaceutical excipients. Accent Microcell Limited deals in all kinds of drugs and medicines, covering various therapeutic areas such as antibiotics, herbal remedies, and veterinary applications. Its business model focuses on manufacturing, importing, and exporting these products to meet demand in multiple healthcare sectors. Accent Microcell Ltd's revenue streams come from selling bulk drugs, pharmaceutical formulations, and healthcare products to distributors, pharmacies, and veterinary suppliers. The company's diverse portfolio of over 200 products ensures steady demand across different therapeutic segments, supporting consistent sales in both human and veterinary healthcare markets. Accent Microcell is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Accent Microcell stock

Cash Return on Invested Capital (CROIC) of Accent Microcell is 6.38 % in 2025.

Cash Return on Invested Capital (CROIC) of Accent Microcell changed from 5.29 % to 6.38 %, representing a 20.57% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Cash Return on Invested Capital (CROIC) Accent Microcell since 2006 – with annual values, charts, and detailed analysis.

CROIC measures the cash return generated on invested capital. Unlike ROIC, it uses free cash flow instead of accounting earnings, providing a purer profitability measure.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Return on Invested Capital (CROIC)'s Accent Microcell with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Return on Invested Capital (CROIC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Return on Invested Capital (CROIC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Profitability — Accent Microcell

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — Accent Microcell